China Medicine Stock Current Ratio
| CHME Stock | USD 0.0002 0.0001 100.00% |
China Medicine fundamentals help investors to digest information that contributes to China Medicine's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Medicine pink sheet.
China |
China Medicine Company Current Ratio Analysis
China Medicine's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current China Medicine Current Ratio | 11.15 X |
Most of China Medicine's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, China Medicine has a Current Ratio of 11.15 times. This is 283.16% higher than that of the Pharmaceuticals sector and notably higher than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
China Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medicine's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medicine could also be used in its relative valuation, which is a method of valuing China Medicine by comparing valuation metrics of similar companies.China Medicine is currently under evaluation in current ratio category among its peers.
China Fundamentals
| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 2 M | |||
| Shares Outstanding | 23.71 M | |||
| Price To Earning | (6.67) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 64.75 M | |||
| Gross Profit | 18.98 M | |||
| EBITDA | 13.41 M | |||
| Net Income | 1.72 M | |||
| Cash And Equivalents | 7.85 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 4.05 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 11.15 X | |||
| Book Value Per Share | 1.97 X | |||
| Cash Flow From Operations | 16.96 M | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 281 | |||
| Beta | 36.82 | |||
| Market Capitalization | 284.54 K | |||
| Total Asset | 66.84 M | |||
| Retained Earnings | 24.76 M | |||
| Working Capital | 85.75 M | |||
| Current Asset | 94.2 M | |||
| Current Liabilities | 8.45 M | |||
| Z Score | 1.2 | |||
| Net Asset | 66.84 M |
About China Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.